654 related articles for article (PubMed ID: 17255769)
1. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
3. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
4. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
[TBL] [Abstract][Full Text] [Related]
6. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
7. Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma.
Chuang HC; Hsu SC; Huang CG; Hsueh S; Ng KF; Chen TC
Pathol Int; 2013 Dec; 63(12):573-80. PubMed ID: 24422953
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
West RB
Adv Anat Pathol; 2010 Sep; 17(5):366-73. PubMed ID: 20733355
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
Foo WC; Cruise MW; Wick MR; Hornick JL
Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
[TBL] [Abstract][Full Text] [Related]
10. First case report of a fetal synovial sarcoma confirmed by molecular detection of SYT-SSX fusion gene transcripts.
Duband S; Morrison AL; Pasquier D; Coindre JM; Pasquier B; Péoc'h M
Am J Perinatol; 2008 Sep; 25(8):517-20. PubMed ID: 18720326
[TBL] [Abstract][Full Text] [Related]
11. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
Tvrdík D; Povýsil C; Svatosová J; Dundr P
Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
[TBL] [Abstract][Full Text] [Related]
13. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
[TBL] [Abstract][Full Text] [Related]
14. Radiation-associated synovial sarcoma: clinicopathologic and molecular analysis of two cases.
Egger JF; Coindre JM; Benhattar J; Coucke P; Guillou L
Mod Pathol; 2002 Sep; 15(9):998-1004. PubMed ID: 12218218
[TBL] [Abstract][Full Text] [Related]
15. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
16. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
[TBL] [Abstract][Full Text] [Related]
17. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study.
O'Sullivan MJ; Kyriakos M; Zhu X; Wick MR; Swanson PE; Dehner LP; Humphrey PA; Pfeifer JD
Mod Pathol; 2000 Nov; 13(11):1253-63. PubMed ID: 11106084
[TBL] [Abstract][Full Text] [Related]
18. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
19. Ossifying synovial sarcoma.
Hisaoka M; Matsuyama A; Shimajiri S; Akiba J; Kusano H; Hiraoka K; Shoda T; Hashimoto H
Pathol Res Pract; 2009; 205(3):195-8. PubMed ID: 19041192
[TBL] [Abstract][Full Text] [Related]
20. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
